Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Conditions
Interventions
Placebo Capsules + Placebo Patch
Placebo capsules + Lidoderm®
+4 more
Locations
7
United States
Birmingham, Alabama, United States
Hueytown, Alabama, United States
Phoenix, Arizona, United States
Pembroke Pines, Florida, United States
New York, New York, United States
Rochester, New York, United States
Start Date
January 1, 2003
Primary Completion Date
June 1, 2003
Last Updated
January 2, 2024
NCT07473635
NCT05777889
NCT05052736
NCT06290661
NCT04144972
NCT07000409
Lead Sponsor
Endo Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions